A Clinical Study to Evaluate the Safety and Efficacy of Brahmi Ghrita and Shankhapushpi Panak in the Management of Chittodvega with special reference to Generalized Anxiety Disorder.

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patient willing to sign the consent form.
•2. Patients of either sex with age between 18 to 60 years.
•3. Patient fulfilling the Diagnostic and Statistical Manual of Mental Disorder , Fourth Edition (DSM â?? IV).
•4. Patient who score at least 14 on the Hamilton Anxiety Rating Scale (HARS â?? A) at baseline visit.

•1.Chittodvega is due to direct physiological effect of a substance (e.g. A drug abuse, a medication ) or a general medical condition (e.g. Hyperthyroidism).
•2.Occurence of Chittodvega exclusively during mood disorder, a psychotic disorder or a pervasive development disorder.
•3.Patients having chronic diseases like Diabetes Mellitus, Ischemic Heart Disease, Dyslipidaemia, Hypertension, Malignancies, Chronic Renal Failure, any Endochrinological disorders etc. will be excluded.
•4.Patients who have completed participation in any other clinical trial during the past six months.
•5.Pregnant or lactating women.
•6.Any other condition which the Investigator thinks may jeopardize the study.
•7.Patients receiving Anxiolytic Drugs will be excluded.

发起方